Jump to navigation
Synthetic cannabinoids are more potent than cannabis and exhibit effects more typically associated with psychostimulants, a new study has found.
NCETA was invited by Business SA to participate in the launch, on Friday 27 July, 2018, of their Ice at Work white paper dealing with methamphetamine and other drug use in the workplace.
Register for NDRI’s 2018 Annual Symposium, this year taking place in Melbourne on Thursday 22 November.
The winner of the National Competition for Excellence in Hepatitis C Health Promotion was announced by CSRH and NDRI on World Hepatitis Day 2018.
NDRI researchers have recently presented two free webinars that are now available online.
NDRI is leading a clinical trial to establish whether a new medication can help people reduce their ice use.
This study is part of the POINT (Pain and Opioids in Treatment) study being conducted by the National Drug and Alcohol Research Centre at UNSW Sydney.
Aboriginal and Torres Strait Islander students from Western Sydney and Tasmania will have their stories included in a culturally inclusive school-based drug and alcohol prevention program.
Results of a four-year study of over 1,500 Australians prescribed opioids for chronic non-cancer pain, suggest there is a need for caution in the use of medicinal cannabis for chronic pain.
Registration for the 2018 NDARC Annual Research Symposium is now open. This year’s theme is clinical, community and policy responses to emerging problems in drug and alcohol use.
Adolescents who drink weekly before age 17 are two to three times more likely to binge drink, drink drive, and be dependent on alcohol in adulthood compared with peers who don’t drink.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Tuesday 15 October 2019